ID UBP37_BOVIN Reviewed; 981 AA. AC F1N5V1; DT 21-SEP-2011, integrated into UniProtKB/Swiss-Prot. DT 03-MAY-2011, sequence version 1. DT 27-MAR-2024, entry version 69. DE RecName: Full=Ubiquitin carboxyl-terminal hydrolase 37; DE EC=3.4.19.12 {ECO:0000250|UniProtKB:Q86T82}; DE AltName: Full=Deubiquitinating enzyme 37; DE AltName: Full=Ubiquitin thioesterase 37; DE AltName: Full=Ubiquitin-specific-processing protease 37; GN Name=USP37; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=19390049; DOI=10.1126/science.1169588; RG The bovine genome sequencing and analysis consortium; RT "The genome sequence of taurine cattle: a window to ruminant biology and RT evolution."; RL Science 324:522-528(2009). CC -!- FUNCTION: Deubiquitinase that plays a role in different processes CC including cell cycle regulation, DNA replication or DNA damage CC response. Antagonizes the anaphase-promoting complex (APC/C) during CC G1/S transition by mediating deubiquitination of cyclin-A (CCNA1 and CC CCNA2), thereby promoting S phase entry. Specifically mediates CC deubiquitination of 'Lys-11'-linked polyubiquitin chains, a specific CC ubiquitin-linkage type mediated by the APC/C complex. Phosphorylation CC at Ser-628 during G1/S phase maximizes the deubiquitinase activity, CC leading to prevent degradation of cyclin-A (CCNA1 and CCNA2). Plays an CC important role in the regulation of DNA replication by stabilizing the CC licensing factor CDT1. Plays also an essential role beyond S-phase CC entry to promote the efficiency and fidelity of replication by CC deubiquitinating checkpoint kinase 1/CHK1, promoting its stability. CC Sustains the DNA damage response (DDR) by deubiquitinating and CC stabilizing the ATP-dependent DNA helicase BLM. Mechanistically, DNA CC double-strand breaks (DSB) promotes ATM-mediated phosphorylation of CC USP37 and enhances the binding between USP37 and BLM. Promotes cell CC migration by deubiquitinating and stabilizing the epithelial- CC mesenchymal transition (EMT)-inducing transcription factor SNAI. Plays CC a role in the regulation of mitotic spindle assembly and mitotic CC progression by associating with chromatin-associated WAPL and CC stabilizing it through deubiquitination. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide CC and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76- CC residue protein attached to proteins as an intracellular targeting CC signal).; EC=3.4.19.12; Evidence={ECO:0000250|UniProtKB:Q86T82}; CC -!- SUBUNIT: Interacts with FZR1/CDH1. Interacts with CDT1. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q86T82}. CC Chromosome {ECO:0000250|UniProtKB:Q86T82}. CC -!- DOMAIN: The KEN box 3 is required for interaction with FZR1/CDH1 and is CC essential for APC(CDH1)-mediated ubiquitination. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- PTM: Polyubiquitinated via 'Lys-11'-linked ubiquitin by the APC(CDH1) CC complex during late mitosis, leading to its degradation. Able to CC mediate auto-deubiquitination. {ECO:0000250|UniProtKB:Q86T82}. CC -!- PTM: Phosphorylated at Ser-630 by CDK2 during G1/S phase but not during CC mitosis; phosphorylation at Ser-630 is required for deubiquitinase CC activity. Also polyubiquitinated during early G1 phase, without leading CC to degradation. Phosphorylated at Ser-114 by ATM following DNA damage, CC which in turn increases its deubiquitination activity towards BLM. CC {ECO:0000250|UniProtKB:Q86T82}. CC -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AAFC03077731; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AAFC03103854; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AAFC03103857; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR RefSeq; NP_001258921.1; NM_001271992.1. DR RefSeq; XP_010800620.1; XM_010802318.2. DR RefSeq; XP_010800621.1; XM_010802319.2. DR RefSeq; XP_010800622.1; XM_010802320.2. DR AlphaFoldDB; F1N5V1; -. DR SMR; F1N5V1; -. DR IntAct; F1N5V1; 1. DR STRING; 9913.ENSBTAP00000057573; -. DR PaxDb; 9913-ENSBTAP00000038058; -. DR Ensembl; ENSBTAT00000081874.1; ENSBTAP00000057573.1; ENSBTAG00000016572.5. DR GeneID; 407168; -. DR KEGG; bta:407168; -. DR CTD; 57695; -. DR VEuPathDB; HostDB:ENSBTAG00000016572; -. DR VGNC; VGNC:36726; USP37. DR eggNOG; KOG1868; Eukaryota. DR GeneTree; ENSGT00940000158091; -. DR HOGENOM; CLU_012557_0_0_1; -. DR InParanoid; F1N5V1; -. DR OMA; CGEVVNK; -. DR OrthoDB; 227085at2759; -. DR TreeFam; TF323032; -. DR Reactome; R-BTA-5689880; Ub-specific processing proteases. DR Proteomes; UP000009136; Chromosome 2. DR Bgee; ENSBTAG00000016572; Expressed in semen and 110 other cell types or tissues. DR ExpressionAtlas; F1N5V1; baseline and differential. DR GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0004843; F:cysteine-type deubiquitinase activity; ISS:UniProtKB. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB. DR GO; GO:0019901; F:protein kinase binding; IEA:Ensembl. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISS:UniProtKB. DR GO; GO:0016579; P:protein deubiquitination; ISS:UniProtKB. DR GO; GO:0035871; P:protein K11-linked deubiquitination; ISS:UniProtKB. DR GO; GO:0071108; P:protein K48-linked deubiquitination; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0006275; P:regulation of DNA replication; ISS:UniProtKB. DR CDD; cd02257; Peptidase_C19; 2. DR CDD; cd13312; PH_USP37_like; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 2. DR Gene3D; 2.30.29.180; Ubiquitin carboxyl-terminal hydrolase 26/29/37, pleckstrin homology-like domain; 1. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR001394; Peptidase_C19_UCH. DR InterPro; IPR003903; UIM_dom. DR InterPro; IPR032069; USP37-like_PH. DR InterPro; IPR038093; USP37-like_PH_sf. DR InterPro; IPR018200; USP_CS. DR InterPro; IPR028889; USP_dom. DR PANTHER; PTHR21646; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE; 1. DR PANTHER; PTHR21646:SF23; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE USP2; 1. DR Pfam; PF00443; UCH; 1. DR Pfam; PF16674; UCH_N; 1. DR Pfam; PF02809; UIM; 3. DR SMART; SM00726; UIM; 4. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR PROSITE; PS50330; UIM; 3. DR PROSITE; PS00972; USP_1; 1. DR PROSITE; PS00973; USP_2; 1. DR PROSITE; PS50235; USP_3; 1. PE 3: Inferred from homology; KW Cell cycle; Cell division; Chromosome; Hydrolase; Mitosis; Nucleus; KW Phosphoprotein; Protease; Reference proteome; Repeat; Thiol protease; KW Ubl conjugation; Ubl conjugation pathway. FT CHAIN 1..981 FT /note="Ubiquitin carboxyl-terminal hydrolase 37" FT /id="PRO_0000412644" FT DOMAIN 343..953 FT /note="USP" FT DOMAIN 706..725 FT /note="UIM 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT DOMAIN 808..827 FT /note="UIM 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT DOMAIN 830..849 FT /note="UIM 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00213" FT REGION 111..306 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 670..705 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 721..797 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 32..34 FT /note="KEN box 1" FT /evidence="ECO:0000250" FT MOTIF 71..79 FT /note="D-box 1" FT /evidence="ECO:0000250" FT MOTIF 96..105 FT /note="D-box 2" FT /evidence="ECO:0000250" FT MOTIF 160..168 FT /note="D-box 3" FT /evidence="ECO:0000250" FT MOTIF 223..225 FT /note="KEN box 2" FT /evidence="ECO:0000250" FT MOTIF 784..786 FT /note="KEN box 3" FT /evidence="ECO:0000250" FT COMPBIAS 111..147 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 182..199 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 200..226 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 227..303 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 676..701 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 722..739 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 774..791 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 352 FT /note="Nucleophile" FT /evidence="ECO:0000250|UniProtKB:Q86T82, FT ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE- FT ProRule:PRU10093" FT ACT_SITE 908 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10092, FT ECO:0000255|PROSITE-ProRule:PRU10093" FT MOD_RES 114 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 170 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 212 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 630 FT /note="Phosphoserine; by CDK2" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 652 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 654 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" FT MOD_RES 772 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q86T82" SQ SEQUENCE 981 AA; 110398 MW; 4F678FE4C1D0B5E3 CRC64; MSPLKIHGPI RIRSMQTGIT KWKEGSFEVV EKENKVSLVV HYNTGGIPRI FQLSHNIKNV VLRPSGAKQS RLMLTLQDNS FLSIDKVPSK DAEEMRLFLD AVHQNRLNAA MKPSQGSGSF GAILGSRTSQ KETNRQLSYS DNQVSSKRGS LETKDDTPFR KVLGNPSRGS IKAAAGNGVT PARTIPSLTS TSTPLRSGLL ENRTEKRKRM LSSGSELNED YPKENDSSSN NKAMTDPSRK YLTSSREKQL SLKQSEENRT SGLLPLQSSS FYGSRTAAKD YSPGSTNLDR TNISSQTPSA KRSLGFLPQP APLSVKKLRC NQDYTGWNKP RVPLSSHQQQ QLQGFSNLGN TCYMNAILQS LFSLQSFAND LLKQGIPWKK IPLNALIRRF AHLLVKKDIC NSETKKDLLK KVKNAISATA ERFSGYMQND AHEFLSQCLD QLKEDMEKLN KTWKIEPVPG EENSPDISAT RVYTCPVITN LEFEVQHSII CKVCGEIIPK REQFNDLSID LPRRKKPLPP RSIQDSLDLF FRAEELEYSC EKCGGKCALV RHKFNRLPRI LILHLKRYSF NVALSLNNKI GQQVIIPRYL TLSSHCTENT KPPFNLGWSA QMAVSRPLKA SQMVNSCITS PSTPSKNFTF KSKTSLALSL DSDSEDELKR SVALSHRLCE MSGSEQQQED LEKDSKSCRI EPDKSELENS GFDGMSEEEL LAAVLEISKR EASPSLSHED DDKPTSSPDT GFAEDDIQEM PENPDSVETE KPKTITEPDP ASFTEITKDC DENKENKTPE GSQGEVDWLQ QYDMEREREE QELQQALAQS LQEQEAWEQK EDDDLKRATE LSLQEFNNSF VDSLGSDEDS GNEDVLDMEY TEAEAEELKR NAETGNLPHS YRLISVVSHI GSTSSSGHYI SDVYDIKKQA WFTYNDLEVS KIQEASVQSD RDRSGYIFFY MHKEIFDELL ETEKNSQALN LEVGKTTRQV S //